Immunosurveillance, immunodeficiencies and lymphoproliferations : lymphoproliferative disorders in congenital and acquired immunodeficiencies /
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Berlin ; New York :
Springer,
©2002.
|
| Series: | Recent results in cancer research
159. |
| Subjects: |
Table of Contents:
- Immunosurveillance, immunodeficiency and lymphoproliferations
- Clinicopathological characteristics of post-transplant lymphoproliferative disorders
- Iatrogenic lymphoproliferative disorders in non-transplantation settings
- The role of Kaposi's Saracoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases
- Dendritic cells for the induction of EBV immunity
- NF-[kappa]B inhibition in EBV-transformed lymphoblastoid cell lines
- Epstein-Barr viral load as a tool to diagnose and monitor post-transplant lymphoproliferative disease
- The role of immunosuppression in lymphoma
- Identification of prognostic factors in post-transplant lymphoproliferative disorders
- Methods and objectives of a large US multicenter case-control study of post-transplant lymphoproliferative disorder in renal transplant patients
- Antiviral treatment of Epstein-Barr virus-associated lymphoproliferations
- Low-dose chemotherapy for children with post-transplant lymphoproliferative disease
- Engineered antibody for treating lymphoma
- Treatment of post-transplant lymphomas with anti-B-cell monoclonal antibodies
- Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas
- Non-myeloablative stem cell transplantation for congenital immunodeficiencies
- Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma
- Infusional CDE with Rituximab for the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: preliminary results of a phase I/II study.